Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2008
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1979314A2 Indole sulfonamide modulators of progesterone receptors
10/15/2008EP1978959A2 Piperidine and piperazine derivatives
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008EP1569901B1 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
10/15/2008EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287727A Novel high affinity quinoline-based kinase ligands
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101284829A Conjugates of ascorbic acid and polyamide and method for preparing same
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
10/15/2008CN100425592C Indole derivatives
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435824 Prodrugs of potassium channel inhibitors
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120725A1 Novel pyrrolinone derivative and medicinal composition containing the same
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008119771A2 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
10/09/2008WO2008119718A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119714A1 Compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119712A1 Benzoimidazole derivatives which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008119711A1 Substituted benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
10/09/2008WO2008098978A3 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
10/09/2008WO2008092942A3 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
10/09/2008WO2008062276A8 Acetylene derivatives as stearoyl coa desaturase inhibitors
10/09/2008WO2008005955A3 Synthesis of heterocyclic compounds
10/09/2008WO2008002245A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2008002244A8 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3)
10/09/2008WO2007149478A3 Pyrazine derivatives with extended conjugation and uses thereof
10/09/2008US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids
10/09/2008US20080249119 Nucleosiding a protected cytosine with a protected hexose, deprotecting to obtain gemcitabine; administering as produgs; cancers of the lungs, ovaries, pancreas and bladder; cost efficiency; simplification
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978023A1 Pyridazines as fungicides
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976841A1 Heterocyclic amide derivatives as calcium channel blockers
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976381A2 Tri-substituted 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
10/08/2008EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1341785B1 Hydrolysis of r(r*,r*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282967A Total synthesis of pladienolide b and pladienolide D
10/08/2008CN101282966A Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
10/08/2008CN101282942A Imidazole derivatives for the treatment of anxiety and related diseases
10/08/2008CN101282941A Imidazole compounds for the treatment of neurological disorders
10/08/2008CN101282931A Tanaka Hiroaki
10/08/2008CN100424135C Colorants produced by reaction of oxyalkylene-substituted aminophenol intermediate
10/08/2008CN100424078C Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432288 Pyrrole-2,5-dione derivatives as Liver X receptor modulators
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/07/2008US7432280 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432270 N-aroyl cyclic amines
10/07/2008US7432268 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
10/07/2008US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain
10/07/2008US7432263 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
10/07/2008US7432259 Spiro-piperidine derivatives
10/07/2008CA2433772C Pyrimidine matrix metalloproteinase inhibitors
10/07/2008CA2392971C 2,4-diaminopyrimidine compounds useful as immunosuppressants
10/07/2008CA2225022C New polymorphous form of doxazosine mesylate (form iii)
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008117955A1 Process for preparing of 2'-deoxy-2'2'-difluorocytidine
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117707A1 Ground crystal of olmesartan medoxomil
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 694